Clinical Trials for Non Small Cell Lung Cancer

Find clinical trials for non small cell lung cancer. Discover research opportunities and treatment options in your area.

256 Active Trials Found

Showing 256 trials on this page

Page 4 of 13

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

NCT ID: NCT05317858

This clinical trial is studying a new treatment approach for patients with brain tumors caused by non-small cell lung cancer (NSCLC) that have spread to the brain. The researchers want to see if us...

Recruiting

Phase: PHASE3 Type: interventional Locations: Baltimore, Maryland, United States, Providence, Rhode Island, United States +9 more

A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer

NCT ID: NCT07005336

This clinical trial is investigating a new treatment approach for patients with non-small cell lung cancer (NSCLC) that is locally advanced and cannot be surgically removed or has spread to other p...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, , China, Beijing, , China +26 more

3-Dimensional Virtual Reality Modelling With Intravascular Indocyanine Green Fluorescence Mapping for Targeted Pulmonary Segmental Resection Trial

NCT ID: NCT06638125

This clinical trial is studying a new way to perform surgery for patients with early-stage non-small cell lung cancer (NSCLC) using advanced technology. Specifically, the researchers are looking in...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Hamilton, Ontario, Canada

Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression

NCT ID: NCT07001995

This clinical trial is investigating a treatment approach for patients with a specific type of lung cancer called non-small cell lung cancer (NSCLC) that has an EGFR mutation. The study is looking ...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Changsha, Hunan, China

A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer

NCT ID: NCT06984588

This clinical trial is studying the effectiveness of a new treatment combination for patients with a specific type of lung cancer called non-small cell lung cancer (NSCLC) that has not been treated...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, , China, Nanjing, , China +62 more

Phase 2 Study of Fingolimod in Lung Cancers

NCT ID: NCT06424067

This clinical trial is studying the use of a medication called fingolimod (also known as Gilenya) in patients with advanced lung cancers, specifically non-small cell lung cancer (NSCLC) and small c...

Recruiting

Phase: PHASE2 Type: interventional Locations: Charleston, South Carolina, United States

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

NCT ID: NCT03808337

This clinical trial is studying the use of a special type of radiation treatment called Stereotactic Body Radiotherapy (SBRT) for patients with certain types of cancer that have spread from their o...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States, New York, New York, United States +16 more

Observational Basket Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform

NCT ID: NCT05520099

This clinical trial is studying a new diagnostic tool called the Cybrid live tumor diagnostic platform, which aims to help doctors better understand and predict how solid tumors, like certain cance...

Recruiting

Type: observational Locations: Orlando, Florida, United States, Madison, Wisconsin, United States +9 more

A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

NCT ID: NCT05657873

This clinical trial is studying a new treatment approach for people with advanced non-small cell lung cancer (NSCLC) that has spread to the liver. The researchers want to find out if adding a speci...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Allentown, Pennsylvania, United States +7 more

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

NCT ID: NCT05837767

This clinical trial is investigating a new type of radiation therapy called lattice radiation therapy (LRT) to see if it works better than the standard approach known as stereotactic body radiation...

Recruiting

Phase: NA Type: interventional Locations: New York, New York, United States, Harrison, New York, United States +5 more

Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)

NCT ID: NCT06577792

The LOFTY trial is studying the best order of surgery for patients with operable non-small cell lung cancer (NSCLC). Specifically, it compares two approaches: performing lymphadenectomy (removal of...

Recruiting

Phase: NA Type: interventional Locations: Guangzhou, Guangdong, China, Guangzhou, Guangdong, China +31 more

Trial of ctDNA of Guidance to Determine PostOperative Radiation Therapy

NCT ID: NCT06979661

This clinical trial is studying how a test called ctDNA (circulating tumor DNA) can help doctors decide on the best treatment after surgery for patients with non-small cell lung cancer (NSCLC). The...

Not yet recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: New Brunswick, New Jersey, United States

Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)

NCT ID: NCT06524427

The RAVAR clinical trial is comparing two types of surgeries for early-stage non-small cell lung cancer (NSCLC): robot-assisted surgery and video-assisted surgery. Both methods aim to remove cancer...

Recruiting

Phase: NA Type: interventional Locations: Jinan, Shandong, China, Guangzhou, Guangdong, China +23 more

IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)

NCT ID: NCT05742607

The MATISSE clinical trial is studying the safety and effectiveness of a new treatment for patients with early-stage non-small cell lung cancer (NSCLC) that can be surgically removed. Specifically,...

Recruiting

Phase: PHASE2 Type: interventional Locations: Pittsburgh, Pennsylvania, United States, Chicago, Illinois, United States +31 more

DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC

NCT ID: NCT06364917

The DISCERN trial is a research study that aims to compare two different treatment approaches for patients with non-small cell lung cancer (NSCLC) that does not have a specific marker called PD-L1....

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Birmingham, Alabama, United States

Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO)

NCT ID: NCT06219174

This clinical trial is studying a new treatment approach for patients with advanced non-small cell lung cancer (NSCLC) who have a specific genetic mutation called STK11. The researchers are looking...

Recruiting

Phase: PHASE1 Type: interventional Locations: Tampa, Florida, United States

Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C

NCT ID: NCT05631249

This clinical trial is studying a medication called sotorasib for patients with a specific type of lung cancer known as non-small cell lung cancer (NSCLC) that has a mutation called KRAS p.G12C. Th...

Recruiting

Phase: PHASE2 Type: interventional Locations: Lyon, , France, Marseille, , France +3 more

NAD+ Supplement（NMN）With Radioimmunotherapy in Advanced NSCLC

NCT ID: NCT06966583

This clinical trial is investigating whether a supplement called NMN (Nicotinamide Mononucleotide) can be safely used alongside chemotherapy and radiation therapy in patients with advanced non-smal...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Chengdu, Sichuan, China

High-Dose Firmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed in the Treatment of EGFR-Mutated Non-Small Cell Lung Cancer With Leptomeningeal Metastasis

NCT ID: NCT06971406

This clinical trial is studying a combination of treatments for patients with a specific type of lung cancer called non-small cell lung cancer (NSCLC) that has spread to the brain and spinal cord, ...

Not yet recruiting

Phase: PHASE2 Type: interventional

Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC

NCT ID: NCT04585490

This clinical trial is investigating a new treatment approach for patients with stage III non-small cell lung cancer (NSCLC) who have already undergone chemotherapy and radiation therapy. The goal ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Stanford, California, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions